| Literature DB >> 30682781 |
Yi Sun1, Annette Nold2, Ulrich Glitsch3, Frank Bochmann4.
Abstract
In this paper, we critically evaluate the quality of epidemiological evidence on hip osteoarthritis and workload published so far. The influence of study quality on risk estimations was analyzed in sensitivity meta-analyses and meta-regression analyses. Comprehensive searches for epidemiological studies of hip osteoarthritis and occupational workload were performed in literature databases and current reviews. All studies were assessed on the basis of study design, defined quality scores, and relevant confounders considered. In total, 34 suitable studies were identified for critical evaluation. Of these, 20 are prevalence studies and 14 incidence studies. Strong heterogeneity is observed in study design, quality level, and estimated exposure parameters. A consistent positive association between heavy physical workload and hip osteoarthritis was observed only among the male populations, not among the female populations. In general, cohort studies provided lower effect estimates than cross-sectional and population-based case-control studies. Studies with high quality scores also produced lower effect estimates than studies with low quality scores. Consideration of BMI as a confounder in published studies also yielded lower effect estimates than studies without consideration of BMI as a confounder. Our analyses indicate that high-quality studies of the association between occupational workload and hip osteoarthritis provide lower effect estimates than studies of lower quality.Entities:
Keywords: coxarthrosis; meta-analysis; meta-regression analysis; occupational risk; osteoarthritis of the hip; study quality; workload
Mesh:
Year: 2019 PMID: 30682781 PMCID: PMC6388382 DOI: 10.3390/ijerph16030322
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Definition of level of evidence for diagnostic evaluation of studies on osteoarthritis of the hip (score 1–3) [2].
| Diagnosis Criteria | Diagnostic Quality Score * (Evidence Level) |
|---|---|
| Anamnesis/questionnaire: hip pain without clinical check | 1 |
| Hip pain and clinical reduction of movement without radiographic features or | 2 |
| Hip pain with clinical reduction of movement and clearly defined radiographic features (joint space narrowing or Kellgren-Lawrence-score grade 2 and above or comparable criteria) or Diagnosis with indication for THR (total hip replacement) | 3 |
* Score 1—low quality; score 3—high quality.
Definition of quality for exposure assessment of studies on osteoarthritis of the hip (score 1–5) [2].
| Exposure Assessment | Exposure Quality Score * |
|---|---|
| Profession, job title, classification of occupation | 1 |
| Qualitative specification of exposure in different work activities (lifting, climbing stairs, sitting) | 2 |
| Quantitative specification of exposure in different work activities/physical strains with information on intensity (e.g., load weight steps) and duration | 3 |
| Quantitative specification of exposure (as above) with additional plausibility check (e.g., information on daily work output or special controls through video analysis) | 4 |
| Quantitative, measured exposure with quantitative assessment or modeling of hip joint strain | 5 |
* Score 1—low quality; score 5—high quality.
Figure 1PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram for the selection of literature for critical evaluation.
Epidemiological evidence of heavy occupational workload and the risk of hip osteoarthritis.
| Study | Design | Outcome Assessment | Study Population | Quality Score of | Confounders Considered/Controlled | Exposure Parameter Estimated | RR/OR ** (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Size | Age (Years) | Exposure Assessment | Hip OA * Ascertainment | Age | Sex | BMI | Prior Injury | |||||
| Allen 2010 [ | Cross-sectional | Prevalence | 2729 | >45 | 2 | 3 | ✓ | ✓ | ✓ | ✓ | Heavy lifting | 1.67 (1.26–2.23) |
| Andersen 2012 [ | Cohort | Incidence | 2.1 million | 25–59 | 1 | 3 | ✓ | ✓ | ✓ | Farmer | 1.96 (1.84–2.08) | |
| Axmacher 1993 [ | Cross-sectional | Prevalence | 565 farmers | 40–64 | 1 | 2 | ✓ | ✓ | Farmer | 12 (6.7–21.4) | ||
| Coggon 1998 [ | Case-control | Incidence | 611 cases, 611 controls | 45–91 | 3 | 3 | ✓ | ✓ | ✓ | ✓ | Heavy lifting | 2.3 (1.3–4.4) |
| Croft 1992a [ | Cross-sectional | Prevalence | 167 farmers, 83 office staff | 60–76 | 1 | 2 | ✓ | ✓ | Farmer | 9.3 (1.9–44.5) | ||
| Croft 1992b [ | Case-control | Prevalence | 245 cases, 294 controls | 60–75 | 3 | 2 | ✓ | ✓ | Heavy lifting | 2.5 (1.1–5.7) | ||
| Cvijetic 1999 [ | Cross-sectional | Prevalence | 593 | >45 | 2 | 3 | ✓ | ✓ | ✓ | Heavy physical | 1.22 (0.98–2.46) | |
| Elsner 1995 [ | Case-control | Prevalence | 220 cases, 198 controls | Median ca. 50 | 1 | 3 | ✓ | ✓ | Heavy lifting | 1.1 (0.65–2.10) | ||
| Flugsrud 2002 [ | Cohort | Incidence | 50,034 | Mean 55 | 2 | 3 | ✓ | ✓ | ✓ | Heavy physical | 2.10 (1.50–3.00) | |
| Franklin 2010 [ | Case-control | Prevalence | 1408 cases, 1082 controls | ≥60 | 1 | 3 | ✓ | ✓ | ✓ | Farmer | 3.6 (2.1–6.2) | |
| Heliovaara 1993 [ | Cross-sectional | Prevalence | 7217 | ≥30 | 2 | 2 | ✓ | ✓ | ✓ | ✓ | Heavy physical | 2.7 (1.7–4.4) |
| Hubertsson 2017 [ | Cohort | Incidence | 165,179 | 40–70 | 1 | 3 | ✓ | ✓ | Farmer | 1.56 (1.03–2.38) | ||
| Jacobsen 2004a [ | Cross-sectional | Prevalence | 4151 | 22–93 | 3 | 2 | ✓ | ✓ | ✓ | Heavy lifting | 1.0 | |
| Juhakoski 2009 [ | Cohort | Incidence | 840 | 30–72 | 2 | 2 | ✓ | ✓ | ✓ | ✓ | Heavy physical | 6.7 (2.3–19.5) |
| Kaila-Kangas 2011 [ | Cross-sectional | Prevalence | 6556 | 30–97 | 3 | 2 | ✓ | ✓ | ✓ | ✓ | Handling load | 2.3 (1.2–4.3) |
| Lau 2007 [ | Case-control | Prevalence | 138 cases, 414 controls | not given | 3 | 3 | ✓ | ✓ | ✓ | ✓ | Heavy lifting | 4,15 (1.23–14.0) |
| Plotnikoff 2015 [ | Cross-sectional | Prevalence | 4733 | ≥18 | 1 | 3 | ✓ | ✓ | Heavy physical | 1.32 (0.34–5.17) | ||
| Pope 2003 [ | Case-control | Prevalence | 352 cases, 3002 controls | 18–85 | 3 | 1 | ✓ | ✓ | Handling load | 1.74 (1.06–2.86) | ||
| Ratzlaff 2011 [ | Cohort | Incidence | 2918 | 45–85 | 2 | 3 | ✓ | ✓ | ✓ | ✓ | Heavy physical | 1.80 (0.95–2.82) |
| Riyazi 2008 [ | Case-control | Prevalence | 93 cases, 345 controls | 40–79 | 1 | 3 | ✓ | ✓ | Heavy physical | 3.3 (1.3–8.2) | ||
| Roach 1994 [ | Case-control | Prevalence | 99 cases, 233 controls | Mean 68 | 3 | 3 | ✓ | ✓ | ✓ | ✓ | Heavy physical | 2.4 (1.2–4.7) |
| Rubak 2013 [ | Cohort | Incidence | 1.9 million | 31–71 | 3 | 3 | ✓ | ✓ | Heavy physical | 1.33 (1.17–1.53) | ||
| Rubak 2014 [ | Case-control nested | Incidence | 1776 cases, 1776 controls | 41–69 | 3 | 3 | ✓ | ✓ | ✓ | ✓ | Heavy physical | 1.35 (1.05–1.74) |
| Thelin 1990 [ | Case-control | Prevalence | 105 cases, 222 controls | 55–70 | 1 | 3 | ✓ | ✓ | Farmer | 3.2 (1.8–5.5) | ||
| Thelin 1997 [ | Case-control | Prevalence | 216 cases, 479 controls | <70 | 2 | 2 | ✓ | ✓ | Farmer | 4.45 (2.90–6.83) | ||
| Thelin 2004 [ | Case-control | Prevalence | 369 cases, 369 controls | 40–71 | 2 | 3 | ✓ | ✓ | ✓ | Farmer | 13.3 (1.2–145.0) | |
| Thelin 2007 [ | Cohort | Incidence | 3437 | 40–59 | 1 | 2 | ✓ | Farmer | 3.0 (1.7–5.3) | |||
| Tuchsen 2003 [ | Cohort | Incidence | Not given | 20–59 | 1 | 3 | ✓ | ✓ | Farmer | 2.86 (2.62–3.13) | ||
| Vingard 1991a [ | Cohort | Incidence | 250,217 | Not given | 1 | 3 | ✓ | ✓ | Farmer | 3.78 (2.91–3.88) | ||
| Vingard 1991b [ | Case-control | Incidence | 239 cases, 302 controls | 50–70 | 3 | 3 | ✓ | ✓ | ✓ | ✓ | Heavy lifting | 3.31 (1.97–5.57) |
| Vingard 1992 [ | Case-control | Prevalence | 140 cases, 298 controls | 50–69 | 1 | 3 | ✓ | ✓ | Heavy physical | 12.4 (6.7-23.0) | ||
| Vingard 1997 [ | Case-control | Prevalence | 230 cases, 273 controls | 50–70 | 3 | 3 | ✓ | ✓ | ✓ | Heavy lifting | 1.5 (0.9–2.5) | |
| Wang 2011 [ | Cohort | Incidence | 39,023 | 27–75 | 1 | 3 | ✓ | ✓ | ✓ | Heavy physical | 1.13 (0.84–1.52) | |
| Yoshimura 2000 [ | Case-control | Incidence | 114 cases, 114 controls | ≥45 | 3 | 3 | ✓ | ✓ | ✓ | ✓ | Heavy lifting | 4.1 (1.1–15.2) |
* OA: Osteoarthritis ** RR = Relative Risk; OR = Odds Ratio.
Figure 2Meta-analysis of heavy physical workload/heavy lifting and the risk of hip osteoarthritis (all prevalence studies, n = 13).
Figure 3Meta-analysis of heavy physical workload/heavy lifting and the risk of hip osteoarthritis (all incidence studies, n = 9).
Figure 4Meta-analysis of the risk of hip osteoarthritis among farmers in prevalence studies (all prevalence studies, n = 8).
Figure 5Meta-analysis of the risk of hip osteoarthritis among farmers in cohort studies (all incidence studies, n = 5).
Results of meta-analysis depending on the type and quality level of published studies.
| Exposure Parameters Estimated | Type of Studies | Exposure Score | Diagnostic Score | Number of Studies | Overall ES * (95% CI) | Heterogeneity of Studies (I2) |
|---|---|---|---|---|---|---|
| Heavy physical workload/heavy lifting | Prevalence studies | All studies | All studies | 13 | 2.00 (1.34–2.99) | 76% |
| 1–2 | 1–2 | 1 | 2.70 (1.70–4.40) | - | ||
| All Studies | =3 | 9 | 1.92 (1.02–3.59) | 83% | ||
| ≥3 | All studies | 6 | 1.98 (1.53–2.58) | 0% | ||
| ≥3 | =3 | 3 | 1.94 (1.17–3.20) | 30% | ||
| Incidence Studies | ||||||
| Case-control | ≥3 | =3 | 3 | 2.93 (2.00–4.28) | 0% | |
| Cohort | All studies | All studies | 6 | 1.40 (1.03–1.89) | 71% | |
| 1–2 | 1–2 | 1 | 6.70 (2.30–19.50) | - | ||
| All Studies | =3 | 5 | 1.38 (1.12–1.69) | 54% | ||
| ≥3 | =3 | 2 | 1.33 (1.19–1.50) | 0% | ||
| Farmer | Prevalence studies | 1–2 | All studies | 8 | 4.74 (2.84–7.89) | 68% |
| 1–2 | 1–2 | 4 | 5.38 (2.23–12.97) | 79% | ||
| 1–2 | =3 | 4 | 3.97 (2.17–7.26) | 46% | ||
| Incidence studies | ||||||
| Cohort | 1–2 | All studies | 5 | 2.34 (1.55–3.53) | 96% | |
| 1–2 | 1–2 | 1 | 3.00 (1.70–5.30) | - | ||
| 1–2 | =3 | 4 | 2.34 (1.54–3.54) | 97% |
* ES: effect estimate.
Results of meta-analysis depending on the type and quality level of published studies for males.
| Exposure Parameters Estimated | Type of Studies | Exposure Score | Diagnostic Score | Number of Studies | Overall ES * (95% CI) | Heterogeneity of Studies (I2) |
|---|---|---|---|---|---|---|
| Heavy physical workload/heavy lifting | Prevalence studies | All studies | All studies | 8 | 2.25 (1.13–4.47) | 84% |
| 1–2 | 1–2 | 0 | - | - | ||
| All Studies | =3 | 6 | 2.21 (0.85–5.80) | 89% | ||
| ≥3 | All studies | 4 | 2.52 (1.71–3.70) | 0% | ||
| ≥3 | =3 | 2 | 2.74 (1.51–4.96) | 0% | ||
| Incidence studies | ||||||
| Case-control | ≥3 | =3 | 2 | 2.84 (1.91–4.22) | 0% | |
| Cohort | All studies | All studies | 3 | 1.40 (1.07–1.82) | 66% | |
| 1–2 | 1–2 | 0 | - | - | ||
| All Studies | =3 | 3 | 1.40 (1.07–1.82) | 66% | ||
| ≥3 | =3 | 2 | 1.33 (1.19–1.50) | 0% | ||
| Farmer | Prevalence studies | 1–2 | All studies | 7 | 4.69 (2.78–7.89) | 71% |
| 1–2 | 1–2 | 4 | 5.38 (2.23–12.97) | 79% | ||
| 1–2 | =3 | 3 | 3.85 (2.06–7.21) | 56% | ||
| Incidence studies | ||||||
| Cohort | 1–2 | All studies | 5 | 2.34 (1.56–3.53) | 96% | |
| 1–2 | 1–2 | 1 | 3.00 (1.70–5.30) | - | ||
| 1–2 | =3 | 4 | 2.34 (1.54–3.54) | 97% |
* ES: effect estimate.
Results of meta-analysis depending on the type and quality level of published studies for females.
| Exposure Parameters Estimated | Type of Studies | Exposure Score | Diagnostic Score | Number of Studies | Overall ES * (95% CI) | Heterogeneity of Studies (I2) |
|---|---|---|---|---|---|---|
| Heavy physical workload/heavy lifting | Prevalence studies | All studies | All studies | 4 | 1.69 (1.04–2.75) | 47% |
| 1–2 | 1–2 | 0 | - | - | ||
| All Studies | =3 | 3 | 2.02 (1.10–3.70) | 42% | ||
| ≥3 | All studies | 3 | 1.69 (0.97–2.94) | 65% | ||
| ≥3 | =3 | 2 | 2.03 (0.94–4.34) | 71% | ||
| Incidence studies | ||||||
| Case-control | ≥3 | =3 | 1 | 0.80 (0.40–1.50) | - | |
| Cohort | All studies | All studies | 3 | 1.06 (0.67–1.69) | 77% | |
| 1–2 | 1–2 | 0 | - | - | ||
| All Studies | =3 | 3 | 1.06 (0.67–1.69) | 77% | ||
| ≥3 | =3 | 2 | 1.01 (0.89–1.15) | 0% | ||
| Farmer | Prevalence studies | 1–2 | All studies | 1 | 0.62 (0.36–1.00) | - |
| 1–2 | 1–2 | 0 | - | - | ||
| 1–2 | =3 | 1 | 0.62 (0.36–1.00) | - | ||
| Incidence studies | ||||||
| Cohort | 1–2 | All studies | 2 | 1.22 (1.12–1.33) | 0% | |
| 1–2 | 1–2 | 0 | - | - | ||
| 1–2 | =3 | 2 | 1.22 (1.12–1.33) | 0% |
* ES: effect estimate.
Results of meta-regressions of all published studies.
| Exposure Parameters Estimated | Independent Parameters in Meta-Regression Model * | β-Values of log (OR/RR) ** | Standard Error (SE) of β-Values |
|---|---|---|---|
| Heavy physical workload/heavy lifting | Cohort study (yes vs. no) | −0.208 | 0.301 |
| Quality score of exposure assessment | −0.183 | 0.210 | |
| Quality score of case assessment | −0.121 | 0.305 | |
| BMI as confounder (yes vs. no) | −0.320 | 0.416 | |
| Prior injury as confounder (yes vs. no) | 0.565 | 0.368 | |
| Farmer | Cohort study (yes vs. no) | −0.877 | 0.375 |
| Quality score of exposure assessment | −0.762 | 0.323 | |
| Quality score of case assessment | −0.450 | 0.390 | |
| BMI as confounder (yes vs. no) | −0.503 | 0.587 | |
| Prior injury as confounder (yes vs. no) | −0.234 | 0.448 |
* All parameters were considered in the same model; ** Sex was adjusted in the meta-regression models.